News
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression ...
The National Centre of Excellence for Sickle Cell Disease Research and Training (NCESRTA) at the Yakubu Gowon University has introduced a 12-week intensive programme designed to strengthen local ...
Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...
ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics ...
Background: Heart failure (HF) is a major public health concern in Bangladesh, responsible for approximately 0.1 million deaths annually and accounting for 15.23% of tot ...
Temperature changes and pollution can have significant impacts on allergies, Gary Falcetano, PA-C, AE-C, US Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, explained in an ...
CBT-I Is the evidence-based first-line treatment, but access gaps persist.
Rehabilitation robotics and Age-Tech leader Zen KOH delivered a featured address and joined a high-level panel at Worl ...
Ethiopia has prioritised high-impact interventions to reduce neonatal deaths, including antenatal corticosteroids (ACS) ...
The medical device industry stands at the convergence of innovative design and stringent regulatory requirements, where design quality engineering serves as the critical bridge between conceptual ...
The University of Abuja’s National Centre of Excellence for Sickle Cell Disease Research and Training (NCESRTA) has launched a capacity-building course for healthcare workers in clinical trials for ...
It’s an unenviable mix of fear and sympathy, and Susan Kurrle understands it well. As a senior geriatrician, she has tended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results